EquityZen Growth Technology Fund LLC - Series 278
Raised
$415K
Investors
14
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 278 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors on August 1, 2018. The fund raised $415K from 14 investors under Regulation D exemptions 506(b) and 3(c)(1), with a $10K minimum investment. This is one of at least 1,891 series vehicles operated by the EquityZen platform for pre-IPO secondary market access.
This pre-IPO fund follows the standard EquityZen template: dual exemptions under 506(b) and 3(c)(1), retail-accessible $10K minimum, and no stated sales compensation. The sub-$500K raise and 14-investor count reflect the platform's typical single-company SPV structure for secondary shares in private growth companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
